Cowen and Company Reiterates Outperform Rating on Auxilium Pharmaceuticals
Posted on January 07, 2013 at 13:07 PM EST
In a report published Monday, Cowen and Company reiterated its Outperform rating on Auxilium Pharmaceuticals (NASDAQ: AUXL ). Cowen and Company noted, “This morning in conjunction with a competitor's conference, Auxilium disclosed 2012 full year product revenues that are within the ranges of previous guidance. This is good news, as